INTUITIVE SURGICAL INC — Director's Dealing 2025

Mar 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2025-02-27

Reporting Person: Curet Myriam (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-27	Common Stock	A	5012	$0.0	Acquired	7766	Direct
2025-02-28	Common Stock	M	1002	$0.0	Acquired	6367	Direct
2025-02-28	Common Stock	F	497	$563.77	Disposed	5870	Direct
2025-02-28	Common Stock	F	2486	$563.77	Disposed	3384	Direct
2025-03-03	Common Stock	S	3031	$577.2955	Disposed	353	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-28	Restricted Stock Units	$0.0	M	1002	Disposed	2026-02-28	Common Stock (1002)	Direct

Footnotes

F1: This transaction represents the certification of the performance goals under performance stock units ("PSUs").

F2: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F3: This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.

F4: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $573.78 to $582.10 as follows: 562 shares sold at $573.78 ; 300 shares sold at $575 to $575.78; 619 shares sold at $576.35 to $577.20; 1,145 shares sold at $578 to $578.88; 105 shares sold at $579.48 to $579.89;and 300 shares sold at $582.03 to $582.10. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F6: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.